Key facts
- This page summarizes Brian S. Posner's Form 5 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jan 2023, 17:31.
Brian S. Posner - 31 Dec 2022 Form 5 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Director
- Issuer ticker
- BIIB
- Reported as of
- 31 Dec 2022
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 27 Jan 2023, 17:31:54 UTC
- Prior SEC filing
- 01 Nov 2022
- Next SEC filing
- 08 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, Attorney in Fact for Brian S. Posner
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian S. Posner filed Form 5 for BIOGEN INC. (BIIB) on 27 Jan 2023.
Change
- Previous filing in this sequence was filed on 01 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -150
- Change %
- -1.8%
- Price
- $0.000000
- Shares after
- 8,025
- Date
- 07 Jun 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Brian S. Posner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.